Ongoing Phase 1/2 Study of MRT-2359 for MYC-driven solid tumors demonstrates favorable safety and pharmacodynamic profile dosing 0.5 mg using…
Toronto, Ontario--(Newsfile Corp. - June 21, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or…
AD04 reduced heavy drinking days among heavy drinking individuals with alcohol use disorder and a specific genetic profile, as identified…
HOUSTON, TEXAS, June 20, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced…
Avenues Recovery Center Opening in Norfolk Will Change the Landscape of Mental Health Care in VirginiaNORFOLK, VA / ACCESSWIRE /…
WARREN, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company…
Celebrating the bold leaders who disrupt markets, revolutionize industries, and transform lives AUSTIN, Texas, June 17, 2024 /PRNewswire/ -- Ernst…
KindlyMD is now providing nearly 80% statewide comprehensive insurance coverage SALT LAKE CITY, UT / ACCESSWIRE / June 17, 2024…
Acquisition expected to be synergistic with FOXO’s epigenetic technology in community health and addiction recovery settings as well as contribute…
STOUGHTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed…